You have no items in your shopping cart.
On Promotion
Tested Applications
Reactivity
Conjugation
Unconjugated 181Biotin 48PE 19FITC 18HRP 16APC 15ALP 6Cy3 6Carrier-free 4Fluoro488 4Fluoro550 4Fluoro594 4Fluoro647 4PE/Cy7 4PerCP 4AP 2APC/Cy5.5 2APC/Cy7 2BF350 2BF405 2BF488 2BF555 2BF594 2BF647 2BF680 2BF700 2BF750 2Cy5 2Cy5.5 2Cy7 2IRDye800 2PE/Cy5 2PE/Cy5.5 2Pacific Blue 2PerCP/Cy5.5 2PerCP/Cy7 2RBITC 2Elab Fluor Violet 450 1
Biologically Active
Featured Product
Search results for: 'IL-17A'
- Featured
Item 1 of 1 - FeaturedItem 1 of 1
- Item 1 of 4
ELISA, FA, FACS, In vivo
Human
Human Humanized
Monoclonal
Unconjugated
100 μg, 1 mg - Item 1 of 4
ELISA, FA, FACS, In vivo
Human
Human Humanized
Monoclonal
Unconjugated
100 μg, 1 mg - Item 1 of 5
ELISA, IHC, WB
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
100 μg - Item 1 of 3
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.26 KDa. Observed: 16 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 15.9 KDa. Observed: 15-22 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.9 KDa. Observed: 15-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgBiotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1&17.8 KDa. Observed: 15-22 KDa, reducing conditions
20 μg, 100 μg
